Retour
Prix Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (02315.HK)
Graphique du cours de l'action 02315.HK
BIOCYTOGEN-B (02315.HK)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HK$50.95
-0.09%
$-0.04
Marché fermé: Feb 16, 12:00:00 HKT
Statistiques clés
Clôture préc.
$53.5
Prix d'ouverture
$51
Plage de la journée
$50.95 - $52.75
Plage de 52 semaines
$7.32 - $63
Volume
18.0K
Volume moyen
1.5M
BPA (TTM)
0.37
Rendement en dividend
--
Capitalisation boursière
$5.4B
Qu’est-ce que BIOCYTOGEN-B ?
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing and currently employs 1,306 full-time employees. The company went IPO on 2022-09-01. The firm utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The firm is also engaged in the provision of gene-editing services. The firm operates its businesses in the domestic market and overseas markets.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.